Literature DB >> 15515571

Serum thymidine kinase activity: an alternative to histologic markers of cellular proliferation in canine lymphoma.

Bruce R Madewell.   

Abstract

Thymidine kinase (TK) is a cellular enzyme which is involved in a 'salvage pathway' of DNA synthesis. It is activated in the G1/S phase of the cell cycle, and its activity has been shown to correlate with the proliferative activity of tumor cells.... Clinical studies have reported high serum TK concentrations in a variety of neoplasias. The majority of these studies concerned hematological malignancies. TK seems to be a useful marker in non-Hodgkin's lymphoma, where it correlates with clinical staging and provides marked prognostic information on (progression-free) survival.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15515571

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  4 in total

1.  Elevated thymidine kinase 1 in serum following neoadjuvant chemotherapy predicts poor outcome for patients with locally advanced breast cancer.

Authors:  Zhi-Heng Huang; Xing-Song Tian; Rong Li; Xian-Ming Wang; Wen Wen; Hong Guan; Ya-Jie Yang
Journal:  Exp Ther Med       Date:  2011-11-28       Impact factor: 2.447

2.  Increased serum level of thymidine kinase 1 correlates with metastatic site in patients with malignant melanoma.

Authors:  Bao-Jin Wu; Wen-Peng Li; Cheng Qian; Wei Ding; Zhong-Wen Zhou; Hua Jiang
Journal:  Tumour Biol       Date:  2012-11-21

3.  Elevated levels of thymidine kinase 1 peptide in serum from patients with breast cancer.

Authors:  Lena Carlsson; Anders Larsson; Henrik Lindman
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

4.  Thymidine Kinase Type 1 and C-Reactive Protein Concentrations in Dogs with Spontaneously Occurring Cancer.

Authors:  K A Selting; R Ringold; B Husbands; P O Pithua
Journal:  J Vet Intern Med       Date:  2016-05-23       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.